Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics (Revised)
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Str...
Labcorp (LH) Surpasses Q4 Earnings and Revenue Estimates (Revised)
Labcorp (LH) came out with quarterly earnings of $3.30 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.05 per share a year ago.
Labcorp (LH) Q4 Earnings and Revenues Beat, Margins Fall
Strength in Diagnostics Laboratories and Biopharma Laboratory Services businesses contributes to Labcorp's (LH) Q4 performance.
Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Conference Call Transcript
Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Conference Call Transcript
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Str...
Labcorp (LH) Surpasses Q4 Earnings and Revenue Estimates
Labcorp (LH) came out with quarterly earnings of $3.30 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $4.14 per share a year ago.
Analysts Estimate Labcorp (LH) to Report a Decline in Earnings: What to Look Out for
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LabCorp (LH) Unveils Test for Preeclampsia in Pregnant Women
LabCorp (LH) test System, which is available through clinicians, is the first FDA-cleared biomarker test to aid in the risk assessment of progression to severe preeclampsia.
LabCorp (LH) to Expand Clinical Trails Access With New Pact
LabCorp (LH) and Hawthorne Effect hope to enhance decentralized clinical trials by merging existing services and developing fresh, unique service offers.
Labcorp (LH) Closes the Legacy Health Asset Acquisition Deal
Labcorp (LH) finalizes the comprehensive laboratory relationship with Legacy Health.
Labcorp (LH) Q3 Earnings and Revenues Beat, Margins Fall
Labcorp (LH) delivers a strong performance in the third quarter of 2023 across the Diagnostics Laboratories and Biopharma Laboratory Services businesses.
Here's What Key Metrics Tell Us About Labcorp (LH) Q3 Earnings
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall St...
Labcorp (LH) Surpasses Q3 Earnings and Revenue Estimates
Labcorp (LH) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.37 per share. This compares to earnings of $4.68 per share a year ago.
Labcorp beats quarterly profit estimates on strength in routine testing segment
Laboratory Corporation of America topped Wall Street expectations for quarterly adjusted profit on Thursday, as strength in its routine diagnostics business more than offset weak COVID test sales.
Labcorp (LH) Launches Biomarker Test for Alzheimer's Disease
Labcorp's (LH) new test, ATN Profile, is likely to accelerate the path to the diagnosis of Alzheimer's disease.
Related Companies